MimoPools™

The latest innovation from the experts in PepSets™ Peptide Library synthesis, MimoPools are uniquely suited to cutting-edge research applications.


These modern peptide libraries are aliquoted and pooled into one convenient peptide mix for maximum manouvereability.

Expanded Applications

MimoPools™ takes standard peptide library screening studiesfurther with critical applications in antigen-specific T-cell response studies, epitope mapping, and immune monitoring.


Pivotal in the continuing worldwide SARS-CoV-2 research, strategically synthesised peptide pools can contain specific sequences for mutations in key proteins or complete protein sequences for each variant.

High Quality Peptides

MimoPools™ are produced using the same validated peptide library synthesis procedureswe’re known for. Our stringentquality control measures guarantee identity and purity, and all peptide pools are supplied with a Certificate of Analysis and Mass Spectrometry data. 


Designed For Success

MimoPools™ are expertly designed on a case-by-case basis to include pre-synthesised catalogue peptides or made-to-order sequences, with all of the modification and customisation option typical of a standard peptide library.


The design of truncated peptide pool has been optimised for T-cell studies by the inclusion of four strategically truncated lengths of the same sequence in each pool.

MimoPools™ are available as-synthesised or purified up to 95%. These peptide pools are supplied as freeze-dried aliquots, offering long-term stability, and allowing MimoPools™ to be used and reused at your convenience.

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

✉ australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

✉ useast@mimotopes.com

✉ uswest@mimotopes.com



asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com


UK / Europe / Africa / Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

  ✉ useast@mimotopes.com 
  ✉ uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com

UK/ Europe/ Africa/ Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Go to article: Home | Technology transformationGo to article: In this issueGo to article: ContentsGo to article: SHL Medical Company Insight Go to article: SHL MedicalGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: CommentGo to article: Tapping into pharma’s growing opportunities in digital healthGo to article: Covid-19 Omicron boosters will reinvigorate injectables manufacturingGo to article: Implementation of electronic health records will improve the quality of careGo to article: Despite benefits, long-acting injectables remain underutilised for schizophreniaGo to article: FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivityGo to article: UK health data collaboration paves the way to study Long Covid symptomsGo to article: Molnar-Institute Company Insight Go to article: Molnar-InstituteGo to article: In DepthGo to article: A makeover for NICE: a new look for HTAs in the UK Go to article: No drugs for prions: investigating new approaches to alleviate therapeutic scarcGo to article: Getting smart with digital pillsGo to article: Do generics producers have what it takes to tackle complex and specialty drugs?Go to article: Decentralised paediatric clinical trials trending up but study execution criticaGo to article: CMO Moves: Regulatory catalysts for drug manufacturing—August Go to article: Biolife SolutionsGo to article: In DataGo to article: Healthtech deals decreased significantly in the pharma industry in H1 2022Go to article: North America is seeing a hiring boom in pharmaceutical industry machine learninGo to article: Artificial intelligence mentions decrease in pharma filings in Q2 of 2022Go to article: Digital media hiring levels in the pharmaceutical industry rose in June 2022Go to article: EventsGo to article: Next issue